The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
OMDA · Healthcare · Narrow moat
On the watchlist
The returnsOnCapital component abstained: Not enough years of ROIC data to score returns on capital. The other four 20% weights were renormalized over the scored 80%.
BBNX · Healthcare · Narrow moat
On the watchlist
The returnsOnCapital component abstained: Not enough years of ROIC data to score returns on capital. The other four 20% weights were renormalized over the scored 80%.
| Measure | OMDA | BBNX | PEN | STE |
|---|---|---|---|---|
| Moat Score (0–100) | 65 (highest) | 65 (highest) | 65 (highest) | 65 (highest) |
| Methodology version | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 |
| Business trend | 70 | 60 | 90 | 93 (highest) |
| Pricing power | 95 | 92 | 100 (highest) | 73 |
| Returns on capital | — | — | 4 | 16 (highest) |
| Balance-sheet safety | 55 | 55 | 73 | 82 (highest) |
| Capital allocation | 39 | 54 | 60 (highest) | 60 (highest) |
| No price data | No price data | 6707% above value if growth stopped today | 223% above value if growth stopped today (largest discount to value if growth stopped today) | |
| Market cap | $1.2B | $703M | $12.5B | $20.9B |
| Moat tier | Narrow moat | Narrow moat | Narrow moat | Narrow moat |
| Filing date | FY2025 | FY2025 | FY2025 | FY2026 |